Must-Have Medications: Life-Saving Drugs Explained For Health

Must-Have Medications: Life-Saving Drugs Explained For Health

Must-Have Medications: Life-Saving Drugs Explained For Health

Unfortunately, these drugs are often out of reach because of high prices due to pharmaceutical company market exclusivity.

This study surveyed the availability of 27 priority life-saving medicines in both public and private outlets in Ethiopia. It found that most of the medicines were unavailable, particularly rectal artesunate, ampicillin 250 mg and 1 g powder for injection and medicinal oxygen.

Manufacturer of Ibrutinib 

Ibrutinib is a drug that prevents cancer cells from growing and spreading. It is an oral medication that works by targeting proteins in the body that promote cell growth and division. It also blocks the activity of protein kinases, which are involved in cell signaling. Ibrutinib is often used in combination with other chemotherapy agents to treat cancer. It is important to tell your doctor about any other medications you are taking or have recently taken.

A new regimen with ibrutinib and fludarabine, manufacturer of lbrutinib, and rituximab may be effective in treating chronic lymphocytic leukemia (CLL). The study found that the combination was superior to standard treatments in achieving a complete remission or better (CR).


This drug, called bevacizumab, is an antibody that targets and kills cancer cells. Avastin also treats wet age-related macular degeneration and diabetic retinopathy (eye disease caused by diabetes that can lead to vision loss).

In clinical studies, Avastin in combination with chemotherapy drugs paclitaxel and carboplatin extended survival for people with advanced nonsquamous non-small cell lung cancer.

Some of the serious side effects that can occur with Avastin include severe stomach pain, bloody or tarry stools, coughing up blood or vomit that looks like coffee grounds, and problems with your vision and balance. Other side effects can include low blood platelet counts, which can increase your risk of bleeding and infections; mouth or nose sores; fever; or changes in your skin color. Call your doctor right away if you have any of these symptoms.

Avastin can also cause liver damage, which may be life-threatening. The FDA weighed the benefits and risks of this medication before approving it for treating ovarian cancer. Its accelerated approval was based on one study with progression-free survival as the primary endpoint and two confirmatory trials. The agency carefully considered advice from its Oncologic Drugs Advisory Committee and the public.

Avastin can harm a developing baby, so women who are able to become pregnant should not receive this medication. It’s also important to use effective birth control while receiving this drug and for 6 months after finishing treatment. You should also not receive this medication if you have a history of bleeds in your stomach, head, or neck.


Carfilzomib is an antineoplastic medication that interferes with the growth of cancer cells.

It is given by IV (intravenous) infusion at a doctor’s office or infusion center. It is usually given once or twice a week. Before receiving this drug, your doctor will perform a blood test to determine if you have low white blood cell counts. If you do, the doctor will delay treatment for a short time until your white blood cell count is higher.

The medication may cause some side effects, including fatigue and a loss of appetite. It may also affect your kidneys, and you will be monitored closely for any signs of this effect. It may also cause changes in the levels of some electrolytes, including potassium. Your healthcare team will monitor your potassium levels throughout treatment. The medication may also lower your ability to fight infections. It is important to tell your doctor right away if you have any signs of infection, including fever, chills, sore throat, cough, or red rash.

Kyprolis is used to treat multiple myeloma, a type of bone marrow cancer. It is often given in combination with other medications, including lenalidomide (Revlimid) and dexamethasone. This combination has shown a high response rate in patients with relapsed or refractory multiple myeloma that has not responded to other treatments. It can also increase the chances of a complete response or minimal response in patients with relapsed or recurring multiple myeloma.

While this treatment is effective, it has serious risks. It can cause a condition called posterior reversible encephalopathy syndrome, which is characterized by headaches, blurred vision, and seizures. The risk of this side effect is greater if you have a preexisting condition such as heart problems or liver disease.

Cyclophosphamide Manufacturer

Overall, iFCG improved progression-free survival compared with FCR alone. It was also associated with a higher rate of CR, a more durable remission, and a lower risk of severe adverse events. However, a small number of sudden unexplained cardiac deaths was observed in the FLAIR study. Therefore, patients with clinically significant cardiac comorbidity should be assessed carefully before starting therapy with cyclophosphamide manufacturer for life.

The FLAIR trial enrolled 258 patients with previously untreated CLL who were fit for combination chemo-immunotherapy. They were randomly assigned to receive either iFCG or fludarabine, cyclophosphamide, plus rituximab. Overall, iFCG improved progression-free and overall survival compared with FCR alone, and the addition of cyclophosphamide improved remission rates in younger patients with unmutated IGHV.


Rituximab (Rituxan, Ruxience, Truxima) is a drug that targets B cells and depletes them of their ability to function. It is used in adults with chronic lymphocytic leukemia (CLL), a cancer that starts in white blood cells; diffuse large B-cell lymphoma (DLBCL); and follicular lymphoma (FL), a less aggressive form of non-Hodgkin lymphoma.

When used with other medications to treat RA, it can decrease symptoms and slow down joint damage. If you develop a sore throat, fever, chills, headache, fatigue or skin rash during rituximab treatment, call your rheumatology team immediately.

Save these numbers in your phone or somewhere safe, as you may need to use them at any time of the day or night. You should avoid herbal remedies and complementary treatments while on rituximab, as they can react with it. It is also important not to get pregnant while on rituximab and for a year after.

About The Author

Post Comment